Bacteroides fragilis Group*
|
|
- Teresa Jade Pope
- 6 years ago
- Views:
Transcription
1 ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 18, No. 4 Copyright 1988, Institute for Clinical Science, Inc. Post-Antibiotic Effect in Bacteroides fragilis Group* DAVID J. SIVERHUS, B.S.,t CHARLES E. EDM ISTON, Jr., PH.D.,f JOHN C. CLAUSZ, Ph.D.,1 and MICHAEL P. GOHEEN M.S.* tsurgical Microbiology Research Laboratory, Department of Surgery, Medical College of Wisconsin, Milwaukee, WI and tdepartment o f Pathology, Indiana University School of Medicine, Indianapolis, IN ABSTRACT Post-antibiotic effect (PAE) is the transient suppression of bacterial growth after brief antimicrobial exposure. While numerous reports have described PAE with aerobic and facultative microorganisms, virtually no studies have been conducted with anaerobic isolates. Intraabdominal isolates of the Bacteroides fragilis group were exposed for one hour to antibiotic (cefoxitin, cefotetan, and imipenem) concentrations two to four times the minimal inhibitory concentration (MIC). Post-antibiotic effect was described as the difference betw een the time required for microbial growth in the test versus the control to increase one Log10 above the quantitation observed immediately after drug removal. Bacteroides fra gilis, B. ovatus, B. thetaiotaomicron and B. vulgatus exhibit PAEs for all test compounds. The time intervals for the PAEs were strain variable and ranged from six to 50 hours. No PAE was demonstrated with B. distasonis strains by the broth dilution technique. The results suggest that brief high dose exposure of some members of the B. fragilis group to anaerobe active beta-lactams produces a prolonged suppression in growth. In theory, a prolonged PAE could influence the dosage regimentation of selective antibiotics. as 1944, it has only recently been recognized as having potential clinical relev an ce.2 M any in vitro stu dies have described PAE s for a wide range of gram p o sitive and gram n egative aerobic microorganisms. T he a e ro b ic gram p o sitiv e cocci exhibit PAE s varying from 0.5 to three $01.80 Institute for Clinical Science, Inc. Introduction While the phenomena of post-antibiotic effect (PAE) was described as early *Address reprint requests to: Charles E. Edmiston, Jr., P h.d., D epartm ent of Surgery, Medical College of Wisconsin, 8700 W. Wisconsin Ave., Milwaukee, WI
2 hours following brief antimicrobial exposu re.3,10 The PAE s w hich have been reported for a number of different antimicrobials against the Enterobacteriaceae appear to be strain variable and dependent upon drug classification. In general, drugs which inhibit protein synthesis produce PAE s of one to five hours in duration in the gram negatives, while the beta-lactams antibiotics appear to be poor inducers of PAE.714 However, imipenem has been dem onstrated to produce a significant PAE with strains of Pseudomonas aeruginosa,9 The post-antibiotic effect has also been dem onstrated in a limited num ber of in vivo animal investigations.8 To date, little data have been presented which docum ent PAE for the anaerobic microbial populations.5 The Bacteroides fragilis group are significant pathogens recove re d from su rg ic a l in fe c tio n s, and together with the Enterobacteriaceae, comprise the predom inant flora associated w ith intraabdom inal sepsis.1 Cefoxitin, cefotetan, and imipenem are b ro ad sp ectru m beta-lactam s w hich dem onstrate good to excellent in vitro anaerobe activity and are often used in the surgical practice. In the presen t study, these th re e antim icrobials are tested against clinical isolates of the Bacteroides fragilis group to assess the presence or absence of a post-an tib io tic effect. Materials and Methods O r g a n is m s Organism s w ere obtained from the Surgical Microbiology Research Laboratory intraabdominal isolate library. Four strains each of Bacteroides fragilis group w ere re c o v e re d from fro zen stock ( 70 C) and streaked to Rrucella blood agar supplem ented with Vitamin K and hemin to check for purity. The following strains w ere used: Bacteroides fragilis POST-ANTIBIOTIC EFFECT IN BACTEROIDES (A203-11, G35-8, A285-28, A400-18); B acteroides vulgatu s (A4, A262-13, A269-11, A301-7); Bacteroides ovatus, (A203-3, A280-15, A324-1, A400-16); Bacteroides thetaiotaomicron (A224-4, A237-17, B276-15, A318-4); and Bacteroides distasonis (A5, A221-6, A248-21, A256-4). None of the test strains was encapsulated and all strains tested positive for beta-lactamase activity by the nitrocefin disk method. M in im a l I n h ib it o r y C o n c e n t r a t io n ( M IC ) The anaerobic isolates were tested for antimicrobial susceptibility by the broth dilution technique.11 Standard antimicrobial pow ders (cefoxitin and im i penem * and cefotetanf) w ere kindly provided by pharmaceutical companies. The anaerobic susceptibilities were perfo rm ed in W ilk in s-c h alg ren b ro th. Briefly, following 48 hours incubation on supplem ented Brucella blood agar, five colonies from each strain w ere inoculated to W ilkins-c halgren bro th and incubated 24 hours at 35 C in an anaerobic chamber. The inoculum was adjusted to a 0.5 McFarland Standard with Wilkins-Chalgren broth. The inoculum density in each tube was approximately 6.0 Log10 colony forming units (cfu) per ml. The tubes were incubated anaerobically at 35 C for 48 hours. The M IC was defined as the lowest concentration of antimicrobial agent that inhibited visual growth of the organism. Bacteroides fra gilis ATCC was included as a control organism to verify drug potency and procedure adequacy. D e t e r m in a t io n o f P o s t -A n t ib io t ic E f f e c t (P A E ) In vitro PAE was determ ined by the broth centrifugation m ethod (11). Bac- *Merck Sharp & Dohme, W est Point, PA. tstuart Pharmaceuticals Inc., Wilmington, DE.
3 3 2 8 SIVERHUS, EDMISTON, CLAUSZ, AND GOHEEN teroides fragilis group test strains were grown overnight (24 hours) in Wilkins- Chalgren broth. The broth cultures were diluted to an optical density of 0.3 at 580 nm and one ml of the adjusted inoculum was added to nine ml of Wilkins-Chalgren broth containing the test antimicrobial and a tube containing 9-ml of antibio tic fre e b ro th (control). T he final microbial concentration in each tube was approximately 7.5 Log10 cfu per ml. The antimicrobials w ere added in test concentrations which varied from two to four times the MIC of the isolate. Test and control cu ltu res w ere incubated anaerobically at 35 C on a rotating rack. At one hour post-antibiotic exposure, the broth cultures were centrifuged (1200 X g for 10 minutes) and washed (3 X ) with buffered diluent to remove the test drug. The control cultures were also washed (3 x ). D rug elim ination was confirmed by the removal of a 200 xl aliquot from the final wash solution for drug quantitation by biological assay (E. coli indicator strain #1346). Following the final wash, antibiotic and control cultures were returned to the rotating rack and incubated anaerobically at 35 C. Samples (100 xl) were removed for quantitative plate counting at 0, 1 (pre and post-wash), 4, 12, 24, 36, and 48 hours (additional sample taken at 96 hours for B. thetaiotaomicron). Dilutions were carried out in buffered gelatin diluent, plated to supplem ented Wilkins-Chalgren agar and incubated anaerobically for 48 hours. Microbial quantitation was expressed as the Log10 cfu per ml. The post-antibiotic effect was defined to be the difference betw een the time required for the colony forming units in the test (T = times in hours) versus contro l (C = tim es in hours) tu b es to in crease 1.0 Log10 above the count observed im m ediately following drug rem oval.4 Therefore, the PAE = T-C: time interval during which normal bacterial grow th was in h ib ited after drug removal. S c a n n in g E l e c t r o n M ic r o s c o p y (S E M ) Bacteroides fragilis strain A and Bacteroides distasonis strain A5 w ere inoculated to Wilkins-Chalgren broth as in the previous PAE procedure. B. fra gilis was tested against cefoxitin and cefotetan while B. distasonis was inoculated to a tube containing im ipenem. The antibiotic concentrations were two times the MIC for cefoxitin and cefotetan (32 xg per ml) and four times the MIC for im ipenem (20 xg per ml). Samples (200 xl) for SEM were removed at initial inoculation and one, 8, 12, 24, 36 and 48 hours post-d rug rem oval. The bro th samples were passed through a 0.45 xm m illipore filter and prefixed for two hours in Karnovsky s fixative at ph 7.2 followed by post-fixation in one percent osm ium tetro x id e.6 Specim ens w ere washed (2 X ) pre and post-fixation in 0.15M sodium cacodylate buffer. Follow ing serial dehydration the filters w ere critical point dried from liquid C 0 2 coated with goldpalladium and observed in a Phillips 500 scanning electron microscope at 25 kv and a spot size of eight nm. Results The post-antibiotic effects for cefoxitin, cefotetan, and imipenem against 20 Bacteroides fragilis group strains are reported in tables I through III. Figures 1 through 3 demonstrate the microbial growth kinetics for selected strains following one hour antimicrobial exposure. Cefoxitin (table I) exhibited a PAE for all B. fragilis strains tested (mean 11.3 hours). Three B. vulgatus isolates demonstrated a PAE with cefoxitin while all strains of B. ovatus exhibited a PAE (Mean 9.4 hours). Two B. thetaiotaomicron strains produced PAE s of 6.5 and 7
4 TABLE I Post-Antibiotic Effect of Cefoxitin Against B a c t e r o i d e s Fragilis Group O r g a n i s m (MIC)* POST-ANTIBIOTIC EFFECT IN BACTEROIDES 32 9 Concent r a t i o nf (ligml) P A E (hrs) B. f r a g i l i s A (16) G35-8 (16) A (16) A (32) B. v u l g a t u s A (8) 16 None A4 (16) A (16) A301-7 (32) B. ovatus A (8) A203-3 (16) A324-1 (16) A (32) B. thetaiotaomicron A224-4 (16) 32 None A (16) B (32) A318-4 (32) 64 None B. d i s t a s o n i s A221-6(8) 16 None A5 (16) 16 None A (16) 32 None A256-4 (16) 64 None *MIC = minimal inhibitory concentration, pg per ml fpost-antibiotic effect (PAE) test concentration and test antimicrobials. The results with B. distasonis were similar to the other two drugs with the exception that strain A221-6 exhibited a PAE of 4.5 hours. Overall, 85 percent of the test isolates exhibited a post-antibiotic effect to imipenem. Figures 1 A through D dem onstrate the PAE kinetics of four B. fragilis group strains following exposure to cefoxitin. W ith the exception of B. distasonis (A5), the growth of the other three isolates exhibited a prolonged growth suppression following drug rem oval. Sim ilar re su lts w ere observed w ith th e te st strains following brief exposure to cefotetan and imipenem (Figures 2 and 3). W hile a significant drop in m icrobial recovery was observed with most strains following drug removal, microbial recovery approximated control values at study end. In general, the shortest PAEs were produced by cefoxitin while the PAEs for hours, respectively. None of the four test strains of B. distasonis exhibited a PAE with cefoxitin. Overall, 65 percent of the B. fragilis group strains exhibited a PAE following brief exposure to cefoxitin. Extended PAE s were documented for cefotetan (table II) with B. fragilis at two times the MIC. Two B. vulgatus strains exhibit a post-antibiotic effect at four times the M IC. Four of the B. ovatus and three of the B. thetaiotaomicron isolates dem onstrated extended PAE s in excess of 18 hours. No PAE was demonstrated with the B. distasonis strains. All strains of the Bacteroides fragilis group w ere tested against im ipenem, (table III) at four times the individual MIC. B. fragilis, B. vulgatus, B. ovatus, and B. thetaiotaom icron all exhibited PAE s w ith im ipenem in excess of 15 hours. The B. thetaiotaomicron strains exhibited the highest PAE s (Range: 24.5 to 50 hours) relative to the other strains TABLE II Post-Antibiotic Effect of Cefotetan Against B a c t e r o i d e s F r a g i l i s Group O r g a n i s m (MIC)* C o n c e n - tration"\ (vgml) P A E (hrs) B. fragilis G35-8 (8) A (8) A (16) A (16) B. vulgatus A4 (4) A (8) A (8) A301-7 (16) B. ovatus A203-3 (16) A (32) A324-1 (32) A (64) B. thetaiotaomicron A224-4 (32) A (32) B (64) A318-4 (64) 128 None B. d i s t a s o n i s A221-6 (16) 32 None A (16) 32 None A5 (32) 64 None A256-4 (32) 64 None *MIC = minimal inhibitory concentration, pg per ml fpost-antibiotic effect (PAE) test concentration
5 3 3 0 SIVERHUS, EDMISTON, CLAUSZ, AND GOHEEN TABLE III Post-Antibiotic Effect of Imipenem Against Bacteroides Fragilis Group Organism (MIC)* Concentrationf (Mgml) PAE (hrs) B. fragilis A (0.5) G35-8 (0.5) A (1) A (1) B. vulgatus A4 (0.5) A (1) A (1) A301-7 (2) B. ovatus A203-3 (0.5) A (0.5) A324-1 (1) A (2) B. thetaiotaomicron A (0.5) A224-4 (1) B (1) A318-4 (2) B. distasonis A5 (0.5) 2 None A221-6 (1) A (2) 8 None A256-4 (2) 8 None *MIC = minimal inhibitory concentration, ug per ml fpost-antiobiotic effect (PAE) test concentration cefotetan were interm ediate to cefoxitin and imipenem (highest). Figures 4 and 5 A -D document the morphologic changes induced in B. fra gilis (A203-11) following one hour exposure to cefotetan and cefoxitin. Cellular elongation was the most common nonlethal defect seen following brief drug exposure. The cellular changes w ere similar to those observed in gram negative cell populations grown in the presence of subinhibitory beta-lactam antimicrobials. No morphologic alterations were seen in B. distasonis (A5) following imipenem exposure (Figures 5 C and D). Discussion The major importance of the post-antibiotic effect resides w ith its potential impact upon the frequency of antimicrobial administration. Theoretically, a prolonged PAE would allow antimicrobial serum and tissue levels to fall below the MIC and still be therapeutically effective. Because of the persistence of inhibitory activity, the dosage interval could conceivably be w idened. H ow ever, there is at present limited clinical evidence which corroborates the in vitro phenomena. Furtherm ore, the administration of high dose antimicrobials in less frequent intervals, while therapeutically valid, may induce a higher incidence of toxicity. Limited clinical trials, utilizing once a day high dose aminoglycoside therapy, appear to be prom ising for facultative infections. H ow ever, the small study populations prevent complete acceptance.1213 The results of the present study suggest that cefoxitin, cefotetan and im i penem are capable of producing a significant PAE at concentrations two to four times the MIC in some members of the Bacteroides fragilis group. The length of the PAE s were variable for the B. fra gilis group isolates. Furtherm ore, the duration of the PAE s were considerably longer than the reported values for aerobicfacultative isolates. It is interesting to note that a number of the strains exhibited MICs that were near or at the resistant breakpoints for cefoxitin and cefotetan. Regardless of this, brief exposure to high level beta-lactams resulted in significant static growth (inhibition range: 6 to 36 hours). As a rule, the cell wall active drugs pro duce relatively short PAE s w hen tested against facultative gram negative microorganisms. The mechanism for the extended PAE s in the B. fragilis group is at present unknown. However, scanning electron microscopy demonstrates that in the case of a susceptible cell population (Figures 4 and 5) the drug can induce non-lethal damage to the cell wall. These non-lethal changes may be precipitated by the covalent binding of the beta-lactams to the penicillin binding proteins (PBPs saturating the active
6 POST-ANTIBIOTIC EFFECT IN BACTEROIDES Co j> O PAE ot Cefoxitin with Bacteroides fragilis A (MIC = 16ugml) PAE of Cefoxitin with Bacteroides vulgatus A4 (MIC = 16ugml) \ e A B -5 9 ' c> I s if I 8 - t CD Z 1 I T ^ a y u_ \ 6 - \ \ - A o -J S 6.5 \ = 5 - \ r V " V. w 6.0 i i i t i i i r t 1 i i i i i r- i i A J LOG TIME IN HOURS I CONTROL ORGANISM * ANTIBIOTIC TIME IN HOURS I CONTROL ORGANISM * ANTIBIOTIC PAE of Cefoxitin with Bacteroides ovatus A203-3 (MIC = I6ugml) PAE of Cefoxitin with Bacteroides distasonis A5 (MIC = 1 6 u g m l) I CONTROL ORGANISM * ANTIBIOTIC l CONTROL ORGANISM ANTIBIOTIC FIGURE 1. Post-Antibiotic effect for B. fragilis (A203-11), B. vulgatus (A4), B. ovatus (A203-3) and B. distasonis (A5) after one hour exposure to cefoxitin. Left and right vertical lines indicate time at which control (solid line) and test (broken line) growth has increased 1.0 Log10 colony forming units following drug removal: PAE = T-C.
7 332 SIVERHUS, EDMISTON, CLAUSZ, AND G O H E E N PAE of Cefotetan with Bacteroides fragilis A (MIC = 16ugml) PAE of Cefotetan with Bacteroides thetaiotaomicron A224-4 (MIC =32ugml) LOG 10 COLONY FORMING UNITS (cfu)ml LOG 10 COLONY FORMING UNITS (cfu)ml CONTROL ORGANISM ANTIBIOTIC PAE of Cefotetan with Bacteroides ovatus A203-3 (MIC = 16ugml) TIME IN HOURS CONTROL * ORGANISM * ANTIBIOTIC PAE of Cefotetan with Bacteroides distasonis A5 (MIC -32ugml) CONTROL ORGANISM ANTIBIOTIC CONTROL * ORGANISM * ANTIBIOTIC F ig u r e 2. Post-antibiotic effect for B. fragilis (A203-11), B. thetaiotaomicron (A224-4), B. ovatus (A203-3) and B. distasonis (A5) after one hour exposure to cefotetan. Left and right vertical lines indicate time at which control (solid line) and test (broken line) growth has increased 1.0 Log10 colony forming units following drug removal: PAE = T-C.
8 I CONTROL «ORGANISM ANTIBIOTIC l CONTROL ORGANISM ANTIBIOTIC POST-ANTIBIOTIC EFFECT IN BACTEROIDES 333 PAE of Imipenem with Bacteroides fragilis G35-8 (MIC = 0.5ugml) PAE of Imipenem with Bacteroides ovatus A203-3 (MIC = 0.5 iflm l) PAE of Imipenem with Bacteroides thetaiotaomicron A224-4 (MIC =1.0 ggml) PAE of Imipenem with Bacteroides distasonis A5 (MIC = O.Sugml) TIME IN HOURS RCONTROL»ORGANISM ANTIBIOTIC I CONTROL ORGANISM * ANTIBIOTIC F ig u r e 3. Post-antibiotic effect for B. fragilis (G35-8), B. ovatus (A203-3), B. thetaiotaomicron (A224-4) and B. distasonis (A5) after one hour exposure to imipenem. Left and right vertical lines indicate time at which control (solid line) and test (broken line) growth has increased 1.0 Log10 colony forming units following drug removal: PAE = T-C.
9 334 SIVERHUS, EDMISTON, CLAUSZ, AND GOHEEN F ig u r e 4. (A) Bacteroides fragilis (A203-11) one hour post-cefotetan removal, cells present on filter exhibit normal morphology (Mag X). (B) Twenty-four hours post-cefotetan removal, numerous filamentous cells present in field (3750 x ). (C) Thirty-six hours post-cefotetan removal, elongated cells demonstrating numer ous (arrows) surface defects (7500 x). (1)) Forty-eight hours post-cefotetan removal, majority of cells have assumed normal morphology. However, a few elongated cells (arrows) remain in culture (3750 X).
10 POST-ANTIBIOTIC EFFECT IN BACTEROIDES 335 F ig u r e 5. (A) Bacteroid.es fragilis (A203-11) culture eight hours post-cefoxitin removal, a few filamentous rods are observed on millipore filter (3750 x). (B) Nearly all B. fragilis cells exhibit normal morphology at 48 hours post-cefoxitin removal (3750x). (C-D ) at 12 and 48 hours post-imipenem removal, Bacteroides distasonis (A5) culture demonstrates normal cellular morphology (7500 x and 1800 x, respectively).
11 3 3 6 SIVERHUS, EDMISTON, CLAUSZ, AND GOHEEN sites) which controls cell wall synthesis. F u rth erm o re, the characteristic slow growth of Bacteroides (relative to facultative organisms) would require a longer period for the synthesis of replacement cellular com ponents required for division. Failure of the B. distasonis and o th e r isolates to exhib it a PAE may reflect variation in species PBP affinity for the test beta-lactam s. At present, most of our knowledge concerning the penicillin binding proteins is limited to aerobic and facultative m icrobial data and little is known about the PBPs in anaerobic microorganisms. In conclusion, cefoxitin, cefotetan and im ipenem pro duce a significant, but variable, post-antibiotic effect with some m em bers of the Bacteroides fra gilis group. The clinical significance of this phenomena in the treatm ent of anaerobic infection is at p resent unknown. However, further studies are necessary to evaluate the frequency of post-antibiotic effect among additional Bacteroides strains and the other clinically important anaerobic populations (clostridia, fusobacteria and peptostreptococci). Acknowledgments Thanks are expressed to Ms. Marcey Jaskulski for h e r technical assistance in the preparation of this manuscript. References 1. A h r e n h o l z, D. H. and S i m m o n s, R. L.: Peritonitis and other intraabdominal infections. Surgical Infectious Diseases. Simmons, R. L. and Howard, R. J., ed. New York, Appleton-Century-Croft, 1982, pp B ig g e r, J. W.: The bactericidal action of penicillin on staphylococcus pyogenes. J. Med. Sci. 227: , B u n d t z e n, R. W., G e r b e r, A. U., C o h n, D. L., and C r a ig, W. A.: Post-antibiotic suppression of bacterial growth. Rev. Infect. Dis. 3:28-37, CRAIG, W. A. and G u d m u n d s s o n, S.: The postantibiotic effect. Antibiotics in Laboratory Medicine. Lorian, V., ed. Baltimore, Williams & Wilkins, 1986, pp C r a ig, W. A. and M a t t ie, H.: Postantibiotic effect (PAE) with Bacteroides fragilis. Twenty- Sixth Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society of Microbiology Abstract No. 147, D a w e s, C. J.: Biological Techniques in Electron Microscopy. New York, Barnes & Noble, Inc., 1971, pp G e r b e r, A. U. an d C r a i g, W.A.: G row th kinetics of respiratory pathogens after short exposures to ampicillin and erythrom ycin in vitro. J. Antimicrob. Chem other. 5:581-91, G u d m u n d s s o n, S., T u r n i d g e, J., V o g e l m a n, B., and C r a ig, W.A.: The postantibiotic effect in vitro. Proceedings of 13th International Congress of Chemotherapy. Spitzy, K. H. and Karrer, K., eds. Vienna, Verlag H. Egerm ann, 1983, pp G u d m u n d s s o n, S., V o g e l m a n, B., and C r a ig, W. A.: The in vivo post-antibiotic effect of imipenem and other new antimicrobials. J. Antimicrob. Chemother. 18:67-73, K nzis, M. D., G u t m a n n, L., and A car, J. F.: Recovery period after exposure of Staphylococcus aureus to subinhibitory and bactericidal concentrations of rifampin: clinical implications. J. Antimicrob. Chem other. 13: Suppl C., 1-7, National C om m ittee for Clinical Laboratory Standards. Alternative Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria: P ro p o sed G u id elin e s N C C L S p u b licatio n M17-D, Villanova, PA, N o r d s t r o m, L., C r o n b e r g, S., R i n b e r g, H., T r e n s t r OM, O., and WALDER, M.: Prospective, comparative, randomized clinical study of aminoglycoside given once a day versus three times a day in severe infections. Recent Advances in Chemotherapy. Ishigami, J., ed. Tokyo, University of Tokyo Press, 1985, P P o w e l l, S. H., T h o m p s o n, W. L., L u t h e, M. A., S t e r n, R. C., G r o s s n ik l a u s, D. A., B l o x h a m, D. D., G r o d e n, D. L., J a c o b s, M. R., D i Sc e n n a, A. O., C a s h, H. A., and Klin g e r, J. D. Once-daily vs continuous aminoglycoside dosing: efficacy and toxicity in animal and clinical studies of gentamicin, netilmicin and tobram ycin. J. Infect. Dis 147: , Vo g e l m a n, B. and C r a ig, W. A.: Kinetics of antimicrobial activity. J. Pediatr. 108: , 1986.
Meropenem: in-vitro activity and kinetics of activity against organisms of the Bacteroides fragilis group
Journal of Antimicrobial Chemotherapy (99) 7, 599-606 Meropenem: in-vitro activity and kinetics of activity against organisms of the Bacteroides fragilis group J. A. Garcia-Rodriguez, J. E. Garcia Sanchez,
More informationABC. Methods for Determining Bactericidal Activity of Antimicrobial Agents; Approved Guideline. Volume 19 Number 18
M26-A ISBN 1-56238-384-1 September 1999 ISSN 0273-3099 Methods for Determining Bactericidal Activity of Antimicrobial Agents; Approved Guideline Volume 19 Number 18 Arthur L. Barry, Ph.D. William A. Craig,
More informationBiofilm Protocol Optimization For Pseudomonas aeruginosa. Introduction. Materials and Methods. Culture Media, Incubation Time, and Biofilm Measurement
Biofilm Protocol Optimization For Pseudomonas aeruginosa Culture Media, Incubation Time, and Biofilm Measurement Introduction In addition to the conventional arsenal of antibiotic resistance mechanisms
More informationPolymicrobial Infection in Mice
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, JUlY 1993, P. 1531-1535 0066-4804/93/071531-05$02.00/0 Copyright 1993, American Society for Microbiology Vol. 37, No. 7 Use of Cephalosporins for Prophylaxis and
More informationSusceptibility Tests
JOURNAL OF CLINICAL MICROBIOLOGY, Aug. 1982, p. 213-217 Vol. 16, No. 2 0095-1137/82/080213-05$02.00/0 In Vitro Studies with Cefotaxime: Disk Diffusion Susceptibility Tests SMITH SHADOMY* AND EDWARD L.
More informationAntibiotic Susceptibility Testing (ABST/AST)
Antibiotic Susceptibility Testing (ABST/AST) Goal Offer guidance to physicians in selecting effective antibacterial therapy for a pathogen in a specific body site. Performed on bacteria isolated from clinical
More informationDETERMINATION OF THE ID50 VALUES OF ANTIBACTERIAL AGENTS IN AGAR. TAKAKO KATO, SATONORI KURASHIGE, Y. A. CHABBERT* and SUSUMU MITSUHASHI
1299 DETERMINATION OF THE ID50 VALUES OF ANTIBACTERIAL AGENTS IN AGAR TAKAKO KATO, SATONORI KURASHIGE, Y. A. CHABBERT* and SUSUMU MITSUHASHI Department of Microbiology, School of Medicine, Gunma University,
More informationDetermination of MIC & MBC
1 Determination of MIC & MBC Minimum inhibitory concentrations (MICs) are defined as the lowest concentration of an antimicrobial that will inhibit the visible growth of a microorganism after overnight
More informationDetermination of MIC & MBC
1 Determination of MIC & MBC Minimum inhibitory concentrations (MICs) are defined as the lowest concentration of an antimicrobial that will inhibit the visible growth of a microorganism after overnight
More informationPharmacokinetics as applied to in vitro and animal models
Pharmacokinetics as applied to in vitro and animal models Michael R. Jacobs, MD, PhD Case Western Reserve University University Hospitals of Cleveland Cleveland, OH Topics In vitro pharmacodynamic models
More informationSpiral Gradient Endpoint Method Compared to Standard Agar Dilution for Susceptibility Testing of Anaerobic Gram-Negative Bacilli
JOURNAL OF CLINICAL MICROBIOLOGY, May 1991, p. 975-979 0095-1137/91/050975-05$02.00/0 Copyright 1991, American Society for Microbiology Vol. 29, No. 5 Spiral Gradient Endpoint Method Compared to Standard
More informationCONTROL OF MICROBIAL GROWTH - DISINFECTANTS AND ANTISEPTICS
CONTROL OF MICROBIAL GROWTH - DISINFECTANTS AND ANTISEPTICS Specific control measures can be used to kill or inhibit the growth of microorganisms. A procedure which leads to the death of cells is broadly
More informationEzy MIC Strip FEATURES AND ADVANTAGES
Imipenem with & without EDTA Ezy MIC Strips (IPM+EDTA/IPM) (Imipenem + EDTA: 1-64 mcg/ml) (Imipenem : 4-256 mcg/ml) Antimicrobial Susceptibility Testing For In Vitro Diagnostic use EM078 Not for Medicinal
More informationFactors Influencing Detection of Tolerance in Staphylococcus aureus
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Sept. 1982, p. 364-368 Vol. 22, No. 3 0066-4804/82/090364-0$02.00/0 Copyright 1982, American Society for Microbiology Factors Influencing Detection of Tolerance in
More informationPostantibiotic Effect of,3-lactam Antibiotics on Escherichia coli Evaluated by Bioluminescence Assay of Bacterial ATP
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Jan. 199, p. 12-16 Vol. 34, No. 1 66-484/9/112-5$2./ Copyright 199, American Society for Microbiology Postantibiotic Effect of,3-lactam Antibiotics on Escherichia
More information2120 Lab. Week 11. Experiments 13,14,21. Kirby Bauer, TDT, Chemicals
2120 Lab Week 11 Experiments 13,14,21 Kirby Bauer, TDT, Chemicals Controlling Microorganisms Decontamination: Physical, chemical, and mechanical methods to destroy or reduce undesirable microbes in a given
More informationPostantibiotic and Sub-MIC Effects of Azithromycin and Isepamicin against Staphylococcus aureus and Escherichia coli
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Feb. 1998, p. 414 418 Vol. 42, No. 2 0066-4804/98/$04.00 0 Copyright 1998, American Society for Microbiology Postantibiotic and Sub-MIC Effects of and against Staphylococcus
More informationEvaluation of the E Test for Susceptibility Testing
JOURNAL OF CLINICAL MICROBIOLOGY, OCt. 1991, p. 2197-2203 0095-1137/91/102197-07$02.00/0 Copyright ) 1991, American Society for Microbiology Vol. 29, No. 10 Evaluation of the E Test for Susceptibility
More informationStudy Title Antimicrobial Activity and Efficacy of Seal Shield's Electroclave. Test Method Custom Device Study. Study Identification Number NG7233
Study Title Antimicrobial Activity and Efficacy of Seal Shield's Electroclave Test Method Custom Device Study Study Identification Number NG7233 Study Sponsor Christian Davis Seal Shield 3105 Riverside
More informationPostantibiotic effect of roxithromycin, erytfaromycin, and clindamycin against selected Gram-positive bacteria and Haemophilus influenzae
Journal of Antimicrobial Chemotherapy (1987) 20, Suppl. B, 39-46 Postantibiotic effect of roxithromycin, erytfaromycin, and clindamycin against selected Gram-positive bacteria and Haemophilus influenzae
More informationIdentification of the In Vivo Pharmacokinetics and Pharmacodynamic Drivers of Iclaprim
AAC Accepted Manuscript Posted Online 29 January 2018 Antimicrob. Agents Chemother. doi:10.1128/aac.02550-17 Copyright 2018 American Society for Microbiology. All Rights Reserved. 1 Identification of the
More informationR IC H A R D C. T IL T O N, Ph.D. A N D L IN D A L IE B E R M A N, B.S.
A n n a l s o f C l i n i c a l a n d L a b o r a t o r y S c i e n c e, Vol. 4, No. 3 Copyright 1974, Institute for Clinical Science M icrodilution Assay o f Antibiotics in Body Flu ids R IC H A R D C.
More information01/08/2018. Control of Microbial Growth. Methods. Terminology. Disinfectants and Antiseptics. Three approaches. Cleaning. Chemical.
Control of Microbial Growth Disinfectants and Antiseptics 1 Methods 2 Three approaches Chemical Disinfectants and antiseptics Physical Heat Ultraviolet Irradiations Mechanical elimination Cleaning Filtration
More informationIntroduction. Results
E valuation of Inhibitory Data of Essential Oil Constituents Obtained w i t h Different Microbiological Testing Methods A. Pauli and K.-H. Kubeczka Department of Pharmaceutical Biology, University of Hamburg,
More informationTest Method for the Continuous Reduction of Bacterial Contamination on Copper Alloy Surfaces
Test Method for the Continuous Reduction of Bacterial Contamination on Copper Alloy Surfaces Test Organisms: Staphylococcus aureus (ATCC 6538) Enterobacter aerogenes (ATCC 13048) Pseudomonas aeruginosa
More informationLab Three :. Sensitivity test:
Lab Three :. Sensitivity test: Or Diffusion Test: Antibiotic sensitivity test: is a laboratory method for determining the susceptibility of organisms to therapy with antibiotics, Antibiotic susceptibility
More informationCONTROL OF MICROBIAL GROWTH - DISINFECTANTS AND ANTISEPTICS
CONTROL OF MICROBIAL GROWTH - DISINFECTANTS AND ANTISEPTICS Specific control measures can be used to kill or inhibit the growth of microorganisms. A procedure which leads to the death of cells is broadly
More informationAntibiotic Susceptibility Testing and Data Interpretation
Antibiotic Susceptibility Testing and Data Interpretation Dr Shabbir Simjee Microbiologist Co-Chair CLSI VAST Basingstoke England Bangkok, 7-8 October 2014 For clarity, these are solely my personal views/opinions
More informationSetting Clinical Breakpoints/ECOFFS
23 rd August 2016 Setting Clinical Breakpoints/ECOFFS Robin A Howe Antimicrobial use in Primary Care An E. coli is grown from blood cultures Cefuroxime MIC 2mg/L Zone around CXM 30ug disc 27mm Is it sensitive?
More information10/2/2016. Control of Microbial Growth. Method. Terminology. Disinfectants and Antiseptics
Control of Microbial Growth Disinfectants and Antiseptics 1 Method Three approaches for the control of microbial growth Chemical Disinfectants and antiseptics Physical Heat Ultraviolet Irradiations Mechanical
More information1. Procedure for Antibiotic susceptibility test by disc diffusion analysis
Nanoparticles Functionalized with Ampicillin Destroy Multiple Antibiotic Resistant Isolates of Pseudomonas aeruginosa, Enterobacter aerogenes and Methicillin Resistant Staphylococcus aureus Ashley Brown
More informationTest Method for Efficacy of Copper Alloy Surfaces as a Sanitizer
Test Method for Efficacy of Copper Alloy Surfaces as a Sanitizer Test Organisms: Staphylococcus aureus (ATCC 6538) Enterobacter aerogenes (ATCC 13048) Pseudomonas aeruginosa (ATCC 15442) Methicillin Resistant
More informationMethodology for Recovery of Chemically Treated Staphylococcus aureus with Neutralizing Medium
APPLIED AND ENVIRONMENTAL MICROBIOLOGY, May 1983, p. 33-37 99-22/83/533-5$2./ Copyright 1983, American Society for Microbiology Vol. 5, No. 5 Methodology for Recovery of Chemically Treated Staphylococcus
More informationobtained from the infected and treated tissues, Fleming's2 technic of hemolytic streptococcus B. Immediately following the infection, 1.0 ml.
THE SENSITIVITY OF STREPTOCOCCI TO PENICILLIN G AFTER EXPOSURE TO THE ANTIBIOTIC IN VIVO* E. GRUNBERG, C. UNGER, AND D. ELDRIDGE Previous investigations by Grunberg, Schnitzer, and Unger3 on the topical
More informationChapter 9 Antimicrobial Susceptibility Testing (Agar Disk Diffusion Method)
Chapter 9 Antimicrobial Susceptibility Testing (Agar Disk Diffusion Method) The disk diffusion method presented in this chapter has been carefully standardized by the National Committee for Clinical Laboratory
More informationAdaptation of a Bacterial Growth Detection Assay on the VICTOR Nivo Multimode Plate Reader for Measurement of Antibiotic Effects
APPLICATION NOTE Multimode Detection Authors: Maria Kuzikov Dr. Bernhard Ellinger Fraunhofer IME ScreeningPort Hamburg, Germany Adaptation of a Bacterial Growth Detection Assay on the VICTOR Nivo Multimode
More informationVerification of Disk Diffusion Tests
Verification of Disk Diffusion Tests Objectives 1. Describe disk diffusion tests 2. Describe process of FDA clearance of susceptibility tests 3. Discuss CLIA requirements for laboratory verification of
More informationStudy Title Antibacterial Activity and Efficacy of KHG FiteBac Technology Test Substance Using a Suspension Time-Kill Procedure
Study Title Antibacterial Activity and Efficacy of KHG FiteBac Technology Test Substance Using a Suspension Time-Kill Procedure Test Method ASTM International Method E2315 Assessment of Antimicrobial Activity
More informationTerminology relating to methods for the determination of susceptibility of bacteria to antimicrobial agents
EUCAST DEFINITIVE DOCUMENT E.Def 1.2 MAY 2000 Terminology relating to methods for the determination of susceptibility of bacteria to antimicrobial agents European Committee forantimicrobial SusceptibilityTesting
More informationMicrobiology for Oral and Topical Products - The basics Scott Colbourne Business Manager NSW ALS Food & Pharmaceutical
Microbiology for Oral and Topical Products - The basics Scott Colbourne Business Manager NSW ALS Food & Pharmaceutical RIGHT S O L U T I O N S RIGHT PARTNER Contents TGO 77 - Introduction Tests Performed
More informationInhibition of Bacteroides fragilis on Blood Agar Plates and Reversal of Inhibition by Added Hemin
JOURNAL OF CLINICAL MICROBIOLOGY, Mar. 1976, p. 359-363 Copyright 1976 American Society for Microbiology Vol. 3, No. 3 Printed in U.S.A. Inhibition of Bacteroides fragilis on Blood Agar Plates and Reversal
More informationUse of the Microbial Growth Curve in Postantibiotic Effect Studies of Legionella pneumophila
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Mar. 2003, p. 1081 1087 Vol. 47, No. 3 0066-4804/03/$08.00 0 DOI: 10.1128/AAC.47.3.1081 1087.2003 Copyright 2003, American Society for Microbiology. All Rights Reserved.
More informationVerification of Gradient Diffusion Strips
Verification of Gradient Diffusion Strips Objectives 1. Describe gradient diffusion tests 2. Describe process of FDA clearance of susceptibility tests 3. Discuss CLIA requirements for laboratory verification
More informationONAMER M. PRESERVATIVE and ANTIMICROBIAL ONAMER
ONAMER M PRESERVATIVE and ANTIMICROBIAL ONAMER M Stepan Lipid Nutrition is a division of Stepan Company which manufactures lipid and polymer based ingredients. HO OH SUMMARY Our quaternary ammonium polymer
More informationReport on New Patented Drugs - Invanz
Report on New Patented Drugs - Invanz October 2006 Under its transparency initiative, the PMPRB publishes the results of the reviews of new patented drugs by Board Staff, for purposes of applying the PMPRB
More informationEM021. Co-Trimoxazole Ezy MIC TM Strip (COT)( mcg/ml) (Trimethoprim/ Sulphamethoxazole) Antimicrobial Susceptibility Testing
Co-Trimoxazole Ezy MIC TM Strip (COT)(0.002-32 mcg/ml) (Trimethoprim/ Sulphamethoxazole) Antimicrobial Susceptibility Testing For In Vitro Diagnostic use EM021 Not for Medicinal Use It is a unique MIC
More informationStaphylococcus aureus
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Nov. 1980, p. 784-788 0066-4804/80/11-0784/05$02.00/0 Vol. 18, No. 5 Effect of Storage and Changes in Bacterial Growth Phase and Antibiotic Concentrations on Antimicrobial
More informationINFLUENCE OF A SUB INHIBITORY CONCENTRATION OF ANTIBIOTICS ON OPSONO-PHAGOCYTIC FUNCTIONS OF KLEBSIELLA PNEUMONIAE BY HUMAN PHAGOCYTES
Influence of sub-mic of antibiotics on phagocytes 1487 INFLUENCE OF A SUB INHIBITORY CONCENTRATION OF ANTIBIOTICS ON OPSONO-PHAGOCYTIC FUNCTIONS OF KLEBSIELLA PNEUMONIAE BY HUMAN PHAGOCYTES YASUO ONO,
More informationASSESSMENT OF THE MICROBICIDAL ACTIVITY OF AN ACCELERATED HYDROGEN PEROXIDE- BASED FORMULATION (AHP-5) AGAINST VRE AND MRSA
Final Report submitted to Virox Technologies Inc. Oakville, Ontario ASSESSMENT OF THE MICROBICIDAL ACTIVITY OF AN ACCELERATED HYDROGEN PEROXIDE- BASED FORMULATION (AHP-5) AGAINST VRE AND MRSA Syed A. Sattar,
More informationBSAC Susceptibility Testing Residential Workshop
BSAC Susceptibility Testing Residential Workshop Susceptibility Testing Methodology Insert name of presentation on Master Slide Mandy Wootton How to determine susceptibility/resistance Minimum Inhibitory
More informationAntimicrobial activity (in vitro) of polysaccharide gel from durian fruit-hulls
ORIGINAL ARTICLE Antimicrobial activity (in vitro) of polysaccharide gel from durian fruit-hulls Vimolmas Lipipun 1, Nantawan Nantawanit 2 and Sunanta Pongsamart 3 Abstract Lipipun, V., Nantawanit, N.
More information3.0. Materials and methods
63 3.0. Materials and methods 3.1. Plant materials and preparation of extracts Salacia oblonga plants were collected from Western Ghats, Karnataka, India. S. oblonga (RRCBI 7881) authentication was done
More informationKrzysztof Sieradzki and Alexander Tomasz* The Rockefeller University, 1230 York Avenue, New York, NY 10021, USA
Journal of Antimicrobial Chemotherapy (1997) 39, Suppl. A, 47 51 JAC Suppression of -lactam antibiotic resistance in a methicillin-resistant Staphylococcus aureus through synergic action of early cell
More informationInfluence of Test Conditions on Antifungal Time-Kill Curve Results: Proposal for Standardized Methods
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, May 1998, p. 1207 1212 Vol. 42, No. 5 0066-4804/98/$04.00 0 Copyright 1998, American Society for Microbiology Influence of Test Conditions on Antifungal Time-Kill
More informationSulfamethoxazole and Trimethoprim: Correlation with a Disk
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Dec. 1981, p. 731-735 Vol. 20, No. 6 0066-4804/81/120731-05$02.00/0 Agar Dilution Susceptibility of Bacteroides spp. to Sulfamethoxazole and Trimethoprim: Correlation
More informationM. Ben-David 1, O. Hammer 1, A.Shinderman 1, Y. Gluckman- Yavo 1, M. Fridman 1, D. Gohman 1, G. Ingber 1 and E. Zahavy 2
437 Fast Antibiotic Susceptibility Testing Utilizing a Unique Spectral Intensity Ratio Analysis via Single Fluorescence Membrane Dye Staining and Flow Cytometry M. Ben-David 1, O. Hammer 1, A.Shinderman
More informationNCCLS Standards for Antimicrobial Susceptibility Tests
CE Update Microbiology III NCCLS Standards for Antimicrobial Susceptibility Tests Clyde Thornsberry, PhD T he most requested test of the clinical microbiology laboratory today is probably t h e antimicrobial
More informationAN EXAMINATION OF THE EFFECTS OF SIMVASTATIN ON INNATE IMMUNE RESPONSES TO S. AUREUS A RESEARCH PAPER BY TRACI STANKIEWICZ
AN EXAMINATION OF THE EFFECTS OF SIMVASTATIN ON INNATE IMMUNE RESPONSES TO S. AUREUS A RESEARCH PAPER BY TRACI STANKIEWICZ SUBMITTED TO THE GRADUATE SCHOOL IN PARTIAL FULFILLMENT OF THE REQUIRMENTS SET
More informationDisk Diffusion Method for Susceptibility Testing of
JOURNAL OF CLINICAL MICROBIOLOGY, Aug. 1991, p. 1604-1609 0095-1137/91/081604-06$02.00/0 Copyright 1991, American Society for Microbiology Vol. 29, No. 8 Disk Diffusion Method for Susceptibility Testing
More informationCHAPTER 24. Immunology
CHAPTER 24 Diagnostic i Microbiology and Immunology Growth-Dependent Diagnostic Methods Isolation of Pathogens from Clinical Specimens Proper sampling and culture of a suspected pathogen is the most reliable
More informationá61ñ MICROBIOLOGICAL EXAMINATION OF NONSTERILE PRODUCTS: MICROBIAL ENUMERATION TESTS
USP 40 Microbiological Tests / á61ñ Microbiological Examination 1 á61ñ MICROBIOLOGICAL EXAMINATION OF NONSTERILE PRODUCTS: MICROBIAL ENUMERATION TESTS INTRODUCTION The tests described hereafter will allow
More informationMicrobiology sheet (6)
Microbiology sheet (6) Made by marah marahleh corrected by : abd. Salman DATE :9/10/2016 Microbial growth / control of microbial growth 1 The method of counting bacteria is divided into: 1) direct 2) indirect
More informationEffect of the growth of anaerobic bacteria on the surface ph of solid media
J Clin Pathol 185;38:565-56 Effect of the growth of anaerobic bacteria on the surface ph of solid media BRIAN WATT, FIONA V BROWN From the Department of Bacteriology, City Hospital, Edinburgh SUMMARY Changes
More informationEffect of the growth of anaerobic bacteria on the surface ph of solid media
J Clin Pathol 185;38:565-56 Effect of the growth of anaerobic bacteria on the surface ph of solid media BRIAN WATT, FIONA V BROWN From the Department of Bacteriology, City Hospital, Edinburgh SUMMARY Changes
More informationMethod Suitability Report Membrane Filtration Sterility Test with QTMicro Apparatus
Method Suitability Report Membrane Filtration Sterility Test with QTMicro Apparatus Bevacizumab (Avastin) 1.25 mg/0.05ml This report provides details on the specifics of a Membrane Filtration Sterility
More informationInvestigational New Drug - Groundwork for in vitro antimicrobial susceptibility testing
Investigational New Drug - Groundwork for in vitro antimicrobial susceptibility testing Erika Matuschek, Ph D Lead Scientist/Operational Manager EUCAST Development Laboratory (EDL) Växjö, Sweden ASM/ESCMID
More informationPERANAN MIKROBIOLOGI DALAM DIAGNOSIS PENYAKIT INFEKSI. dr. Agus Eka Darwinata, Ph.D.
PERANAN MIKROBIOLOGI DALAM DIAGNOSIS PENYAKIT INFEKSI dr. Agus Eka Darwinata, Ph.D. CLINICAL MICROBIOLOGY Clinical microbiology is the discipline of detection, characterization, and quantification of
More informationPenicillin Streptomycin
BTEC 4200 Name Fall 2005 Exam 2 A. Multiple choice (2 pt each) The following choices are used for questions 1 5. Trypan red Arspheniamine (Salvarsan) Sulfonamide Penicillin Streptomycin 1. This substance,
More informationBIO & PHARMA ANALYTICAL TECHNIQUES
BIO & PHARMA ANALYTICAL TECHNIQUES Chapter 11 by Dr. Siti Umairah Mokhtar Faculty of Engineering Technology umairah@ump.edu.my Chapter Description Aims Discuss theory, principles and application of analytical
More informationMIC & Etest. Dr. M. Talebi Ph.D of Bacteriology Tehran University of Medical Sciences
MIC & Etest Dr. M. Talebi Ph.D of Bacteriology Tehran University of Medical Sciences MIC The minimum inhibitory concentration (MIC) is defined as the lowest concentration of the antimicrobial agent required
More informationKILL-TIME STUDIES Antimicrobial Activity of Experimental Solutions Using Legionella pneumophila Test Solution: ACS 200 Submitted June 6, 2012
KILL-TIME STUDIES Antimicrobial Activity of Experimental Solutions Using Legionella pneumophila Test Solution: ACS 200 Submitted June 6, 2012 October 11, 2012 PREPARED FOR: Results RNA 1272 South 1380
More informationFinal text for addition to The International Pharmacopoeia
March 2012 3.3.2 MICROBIOLOGICAL EXAMINATION OF NON-STERILE PRODUCTS: TESTS FOR SPECIFIED MICROORGANISMS Final text for addition to The International Pharmacopoeia This monograph was adopted at the Forty-sixth
More informationENVIRONMENTAL PARAMETERS OF GROWTH
ENVIRONMENTAL PARAMETERS OF GROWTH The growth and survival of microorganisms are affected by the chemical and physical conditions of the external environment. Environmental factors which have significant
More informationINDIAN INSTITUTE OF TECHNOLOGY ROORKEE NPTEL NPTEL ONLINE CERTIFICATION COURSE. Biomedical Nanotechnology
INDIAN INSTITUTE OF TECHNOLOGY ROORKEE NPTEL NPTEL ONLINE CERTIFICATION COURSE Biomedical Nanotechnology Lec-19 In Vitro Methods of Study Antibacterial and Anticancer Properties of Nanomaterials Dr. P.
More informationIN THIS SECTION MICROBIOLOGY TESTING EXPERT SOLUTIONS FOR PRODUCT DEVELOPMENT. Bacterial Endotoxin (LAL) Testing
EXPERT SOLUTIONS FOR PRODUCT DEVELOPMENT IN THIS SECTION MICROBIOLOGY TESTING Microbial assays involve a variety of tests, from the determination of the numbers and types of organisms naturally present
More informationá62ñ MICROBIOLOGICAL EXAMINATION OF NONSTERILE PRODUCTS: TESTS FOR SPECIFIED MICROORGANISMS
USP 40 Microbiological Tests / á62ñ Microbiological Examination 1 á62ñ MICROBIOLOGICAL EXAMINATION OF NONSTERILE PRODUCTS: TESTS FOR SPECIFIED MICROORGANISMS INTRODUCTION The tests described hereafter
More informationENVIRONMENTAL PARAMETERS OF GROWTH
ENVIRONMENTAL PARAMETERS OF GROWTH The growth and survival of microorganisms are affected by the chemical and physical conditions of the external environment. Environmental factors which have significant
More informationThe University of Jordan
The University of Jordan Faculty: Pharmacy Department: Pharmaceutics & Pharmaceutical technology Program: Pharmacy & Pharm D Academic Year/ Semester: 2013/2014 Pharmaceutical Microbiology II (Course Number:
More information6/28/2016. Control of Microbial Growth. Method. Terminology. Disinfectants and Antiseptics
Control of Microbial Growth Disinfectants and Antiseptics 1 Method Three approaches for the control of microbial growth Chemical Disinfectants and antiseptics Physical Heat Ultraviolet Irradiations Mechanical
More informationMICROBIOLOGICAL EXAMINATION OF NON-STERILE PRODUCTS: TEST FOR SPECIFIED MICRO-ORGANISMS Test for specified micro-organisms
5-2-3. Most-probable-number method Prepare and dilute the sample using a method that has been shown to be suitable as described in section 4. Incubate all tubes at 30-35 C for 3-5 days. Subculture if necessary,
More informationRapid Diagnostic Tests for Antimicrobial Resistance: Comparability of Results and Interpretation of Data
Rapid Diagnostic Tests for Antimicrobial Resistance: Comparability of Results and Interpretation of Data Christopher Teale, Animal and Plant Health Agency, UK. 12 th OIE One-Day Seminar, in association
More informationINTRODUCTION Sanitization sterilization Antibiotics Bactericidal Bacteriostatic Antiseptics disinfectants
INTRODUCTION Infectious agents on environmental surfaces, given the correct circumstances, may potentially find their way into an unsuspecting victim. Thus, it is important to keep the surfaces we regularly
More informationActivity of meropenem and other antimicrobial agents against uncommon Gram-negative organisms
Journal of Antimicrobial Chemotherapy (993) 3, 33-37 Activity of and other antimicrobial agents against uncommon Gram-negative organisms Richard B. Clark and Suzanne E. Joyce Department of Pathology, Crozer-Chester
More informationMechanisms of the post-antibiotic effects induced by rifampicin and gentamicin in Escherichia coli
Journal of Antimicrobial Chemotherapy (26) 58, 444 448 doi:1.193/jac/dkl225 Advance Access publication 3 May 26 Mechanisms of the post-antibiotic effects induced by rifampicin and gentamicin in Escherichia
More informationgroup C /8-hemolytic streptococci, a-hemolytic been exposed to penicillin, on the removal of the drug there follows a variable recovery period during
THE RECOVERY OF BACTERIA FROM THE TOXIC EFFECTS OF PENICILLIN1 By HARRY EAGLE (From the Section on Experimental Therapeutics, National Institutes of Health, U. S. Public Health Service, Bethesda 14, Maryland)
More informationCI-867, a New Semisynthetic Penicillin: In Vitro Studies
ANTIROBIAL AGENTS AND CHEMOTHERAPY, Dec. 19, p. 939-943 66-44//12-939/5$2./ Vol. 18, No. 6, a New Semisynthetic Penicillin: In Vitro Studies SUSANNE S. WEAVER AND GERALD P. BODEY* Department of Developmental
More informationThe Effect of Air Pockets on the Efficiency of Disinfection of Respiratory Equipment by Pasteurization
CENORIN MEDICAL INFORMATION SERIES The Effect of Air Pockets on the Efficiency of Disinfection of Respiratory Equipment by Pasteurization Performed by: Bio Research Laboratories, Inc. Cenorin, LLC 6324
More informationMulticenter Evaluation of Four Methods of Yeast Inoculum Preparation
JOURNAL OF CLINICAL MICROBIOLOGY, Aug. 1988, p. 1437-1441 0095-1137/88/081437-05$02.00/0 Copyright C 1988, American Society for Microbiology Vol. 26, No. 8 Multicenter Evaluation of Four Methods of Yeast
More informationRapid Identification of Bacteroides fragilis with Bile and
JOURNAL OF CuNICAL MICROBIOLOGY, Apr. 1977, p. 439-443 Copyright C 1977 American Society for Microbiology Vol. 5, No. 4 Printed in U.S.A. Rapid Identification of Bacteroides fragilis with Bile and Antibiotic
More informationRapid Identification of Bacteroides fragilis with Bile and
JOURNAL OF CuNICAL MICROBIOLOGY, Apr. 1977, p. 439-443 Copyright C 1977 American Society for Microbiology Vol. 5, No. 4 Printed in U.S.A. Rapid Identification of Bacteroides fragilis with Bile and Antibiotic
More informationTest Method of Specified Requirements of Antibacterial Textiles for Medical Use FTTS-FA-002
Test Method of Specified Requirements of Antibacterial Textiles for Medical Use FTTS-FA-002 FTTS-FA-002 Antibacterial Textiles for Medical Use Antibacterial Textiles suppress and even kill harmful bacteria
More informationA study of the in vitro interaction of cotrimoxazole and ampicillin using the checkerboard method
African Journal of Biotechnology Vol. 5 (13), pp. 1284-1288, 3 July 2006 Available online at http://www.academicjournals.org/ajb ISSN 1684 5315 2006 Academic Journals Full Length Research Paper A study
More informationPharmacodynamics of Ampicillin-Sulbactam in an In Vitro Infection Model against Escherichia coli Strains with Various Levels of Resistance
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Feb. 1998, p. 231 235 Vol. 42, No. 2 0066-4804/98/$04.00 0 Copyright 1998, American Society for Microbiology Pharmacodynamics of Ampicillin-Sulbactam in an In Vitro
More informationPostantibiotic effects with Bacteroides fragiris determined by viable counts and COz generation
ORIGINAL ARTICLE Postantibiotic effects with Bacteroides fragiris determined by viable counts and COz generation IDepartments of Clinical Microbiology, Borgarspitalinn (Reykjavik City Hospital), Reykjavik,
More informationStability of Antibiotics and Chemotherapeutics in
APPUED MICROBIOLOGY, Sept. 1970, p. 447-451 Copyright 1970 American Society for Microbiology Vol. 20, No. 3 Printed in U.S.A. Stability of Antibiotics and Chemotherapeutics in Agar Plates KENNETH J. RYAN,
More informationSupplementary Information for
Supplementary Information for Direct, rapid antimicrobial susceptibility test from positive blood cultures based on microscopic imaging analysis J. Choi 1, H. Y. Jeong 2,3, G. Y. Lee 2,4, S. Han 1, S.
More informationPRESERVATIVE EFFICACY TEST FOR COSMETIC PRODUCT
1 SCOPE AND FIELD OF APPLICATION To determine the efficacy of the antimicrobial activity of preservatives used in cosmetic products. The method covers the determination of the suitability of preservation
More informationKILL-TIME STUDIES Antimicrobial Activity of EO H 2 O Using Clostridium difficile spores Test Solutions: Acidic H 2 O Submitted December 12, 2011
KILL-TIME STUDIES Antimicrobial Activity of EO H 2 O Using Clostridium difficile spores Test Solutions: Acidic H 2 O Submitted December 12, 2011 December 20, 2011 PREPARED FOR: Rob Dahl Viritec, LLC. BY:
More informationAntimicrobial and Antibacterial Agents
Antimicrobial and Antibacterial Agents Contents Introduction Classification of antimicrobial drugs Special terms Mechanism of action Resistance of antimicrobial agent Introduction Joseph Lister 1867 -
More informationSystem with BACTEC Radiometric Blood Culture Media
JOURNAL OF CLINICAL MICROBIOLOGY, Oct. 1984, p. 618-623 0095-1137/84/100618-06$02.00/0 Copyright 1984, American Society for Microbiology Vol. 20, No. 4 Clinical Laboratory Comparison of the 10-ml Isolator
More information